Brachial Plexus Injury Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033

The Business Research Company recently released a comprehensive report on the Global Brachial Plexus Injury Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, the brachial plexus injury market size has grown rapidly in recent years. It will grow from $5.1 billion in 2023 to $5.73 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to the increasing incidence of trauma due to road accidents and sports injuries, growing awareness and early diagnosis of brachial plexus injuries, improvements in healthcare infrastructure and accessibility to treatment, a rising geriatric population prone to neurological conditions, the expansion of healthcare insurance coverage for complex surgeries, and regulatory approvals for novel treatment options.

The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to an aging population leading to higher demand for nerve repair solutions, integration of advanced imaging techniques for accurate diagnosis, adoption of minimally invasive surgical procedures, investments in R&D for biologics and tissue engineering, increasing healthcare expenditure in developing economies, and collaboration between medical device companies and research institutions. Major trends in the forecast period include adoption of robotic-assisted surgery for precise nerve reconstruction, growth in telemedicine and virtual consultations for post-operative care, development of bioresorbable materials for nerve conduits, use of artificial intelligence for patient-specific treatment plans, expansion of outpatient surgical centers for quicker recovery times, emphasis on patient-reported outcomes and quality of life improvements, and a and a shift towards personalized medicine and tailored rehabilitation programs.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/brachial-plexus-injury-global-market-report

Market Drivers and Trends:

An increase in the number of road accidents is expected to propel the growth of the brachial plexus injury market going forward. The increased vehicle usage and inadequate enforcement of traffic laws exacerbate risks associated with speeding and driver negligence, leading to a rise in road accident cases. Brachial plexus injury treatment in road accidents typically involves a combination of surgical interventions, such as nerve grafting or nerve transfer procedures, alongside rehabilitative therapies to restore function and mobility to the affected limb. For instance, in January 2024, according to a report published by The Road Safety Authority, an Ireland-based state government agency, as per preliminary traffic collision data, the number of road deaths in 2023 increased by 19% compared to 2022. Therefore, an increase in the number of road accidents is driving the brachial plexus injury market.

Major companies operating in the brachial plexus injury market are developing advanced medical therapies, such as long-acting local analgesics, to enhance pain management. Long-acting local analgesics are pivotal in managing pain in brachial plexus injuries, offering sustained relief via nerve blocks or local infiltration techniques, thus improving patient comfort, supporting rehabilitation, and minimizing systemic side effects associated with traditional pain medications. For instance, in March 2021, Pacira BioSciences Inc., a US-based specialty pharmaceutical company, received FDA approval to expand the label for its non-opioid pain medication EXPAREL (bupivacaine liposome injectable suspension. It contains two additional nerve block indications, such as Adductor canal block, which is used in adult patients to provide regional analgesia for lower extremity treatments, and Sciatic nerve block in the popliteal fossa of adult patients to provide regional analgesia during lower extremity surgeries. The supplemental new drug application (sNDA) is based on two successful Phase 3 studies in which EXPAREL achieved statistically significant and clinically meaningful reductions in postsurgical pain and opioid consumption over 96 hours when compared to bupivacaine HCl after lower extremity surgical procedures such as bunionectomy and total knee arthroplasty.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample_request?id=18268&type=smp

Major Key Players of the Market:

Cardinal Health Inc., Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Smith And Nephew plc, Arthrex Inc., Teleflex Incorporated, Karl Storz SE And Co. KG, Cook Medical LLC, Integra LifeSciences Holdings Corporation, CONMED Corporation, DJO Global Inc., LivaNova PLC, MicroPort Scientific Corporation, Wright Medical Group N.V., AngioDynamics Inc., Pentax Medical

Brachial Plexus Injury Market 2024 Key Insights:

• The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%.
• Impact Of Road Accidents On The Brachial Plexus Injury Market
• Advancements In Pain Management Therapies In The Brachial Plexus Injury Market
• North America was the largest region in the brachial plexus injury market in 2023.

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=18268&type=smp

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.